Answers are grounded in this paper and cite their sources.
Analyses compare cost-effectiveness of ABM/P-15 and Allograft in degenerative spondylolisthesis, indicating improved outcomes with ABM/P-15.
The choice of bone graft material significantly affected cost-effectiveness of posterolateral lumbar fusion in elderly patients with degenerative spondylolisthesis at 10-year follow-up. ABM/P-15 showed dominance over Allograft with improved outcomes, lower healthcare costs and lower re-operation rate.
No takes yet. Share an insight, caveat, or question.
Andresen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: